| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer | President and CEO
3 companies
Southwell David P is a Director at RCKT, with reported holdings spanning 3 companies. Recent filings cover 4 purchases and 19 sales. Those positions are worth an estimated $609K at current prices.
Our model assigns Southwell David P a middling insider score of 65/100, based on 8 past trades. Over a 12-month horizon, 62.5% of those trades were profitable, with an average 12-month return of +24.9%.
Southwell David P's largest disclosed position is in TCRX as Chief Executive Officer, worth about $609K. Net of sales, the recent Form 4 record there shows accumulation of 36,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2025 | PTCT Ptc Therapeutics, Inc. | Director | Sale+OE | 12,000 | $58.34 | $700,080.00 | -41.6% | +31.7% | +15.7% | |
| Apr 15, 2024 | RCKT Rocket Pharmaceuticals, Inc. | Director | Sale+OE | 80,000 | $24.32 | $1,945,784.69 | -41.1% | -6.1% | -72.8% | |
| Apr 17, 2023 | PTCT Ptc Therapeutics, Inc. | Director | Sale+OE10b5-1 | 11,429 | $51.03 | $583,187.14 | -52.1% | -25.1% | -51.0% | |
| Mar 31, 2023 | PTCT Ptc Therapeutics, Inc. | Director | Sale+OE10b5-1 | 2,571 | $50.05 | $128,672.38 | -19.7% | -14.9% | -41.0% | |
| Mar 27, 2023 | PTCT Ptc Therapeutics, Inc. | Director | Sale+OE | 10,000 | $45.10 | $450,955.98 | -48.8% | -11.7% | -38.9% | |
| May 18, 2022 | TCRX Tscan Therapeutics, Inc. | Chief Executive Officer | Buy | 25,000 | $3.59 | $89,821.00 | +17.1% | -12.0% | -8.4% | |
| Sep 8, 2021 | TCRX Tscan Therapeutics, Inc. | Chief Executive Officer | Buy | 11,000 | $8.73 | $96,066.30 | +12.7% | -23.5% | -59.1% | |
| Oct 16, 2020 | PTCT Ptc Therapeutics, Inc. | Director | Sale+OE | 27,000 | $51.54 | $1,391,544.00 | -94.2% | - | - | |
| Dec 13, 2018 | RCKT Rocket Pharmaceuticals, Inc. | Director | Sell | 38,768 | $15.19 | $588,885.92 | -28.9% | - | - | |
| Dec 7, 2018 | RCKT Rocket Pharmaceuticals, Inc. | Director | Sale+OE | 57,732 | $15.13 | $873,458.28 | -30.1% | - | - |